To award task order b-03, "synthesis of non-GMP (1R,4R)-4-(azidomethyl) cyclohexan-1-amine hydrochloride (200 grams)"
Ended Awarded Last action
- Contract number
- 75N93019F00131
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $33,130
Award facts
- Opportunity
-
- NIHAI2017090 Solicitation number
- Nonclinical Services for Development of Interventional Agents for Infectious Diseases Award Notice · Posted Feb 13, 2017
- Contract value 100% obligated
- $33,129.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | -$0 | |
| Original award | $33,130 |
About this award
This is a task order award under the National Institute of Allergy and Infectious Diseases' (NIAID) "Nonclinical Services for Development of Interventional Agents" indefinite delivery, indefinite quantity (IDIQ) contract. The task order, valued at $33,129.70, is for Sri International, a non-profit research and development institute, to synthesize 200 grams of the chemical compound (1R,4R)-4-(azidomethyl) cyclohexan-1-amine hydrochloride. This award does not utilize a small business set-aside. The ultimate completion date for this task order is November 21, 2024. As a prime contractor on multiple IDIQ vehicles with NIAID and other federal agencies, Sri International provides a wide range of scientific, engineering, and technical services to support the government's biomedical research and development efforts.
Quick answers
Who was awarded contract 75N93019F00131?
75N93019F00131 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 27, 2019.
How much is contract 75N93019F00131 worth?
The government has obligated $33,130 on 75N93019F00131.
Is contract 75N93019F00131 an order under another contract?
Yes. 75N93019F00131 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93019F00131 competed?
The extent of competition for 75N93019F00131 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award